Hypogonadism

Adherence to Male Hypogonadism Treatment Guidelines Is Low –

SAN FRANCISCO — Adherence to diagnostic and treatment guidelines for male hypogonadism is quite low, with significant differences among medical specialists, a new study found. Off-label use of testosterone replacement therapy (TRT) has risen in recent years, corresponding with the advent of direct-to-consumer (DTC) advertising for TRT and the emergence of “low T” clinics, Petra […]

Adherence to Male Hypogonadism Treatment Guidelines Is Low – Read More »

Tirzepatide Tops TRT for Men With Hypogonadism and Obesity

San Francisco — Tirzepatide is a promising treatment for metabolic hypogonadism in men with obesity, new research suggested. In a study of 83 men with obesity, functional hypogonadism, and insulin resistance, those treated with the dual glucose-dependent insulinotropic peptide and glucagon-like peptide 1 (GLP-1) receptor agonist tirzepatide for 2 months had greater weight loss, increased

Tirzepatide Tops TRT for Men With Hypogonadism and Obesity Read More »

Scroll to Top